Novo Nordisk vs. Viking Therapeutics: Which GLP-1 Stock is a Safer Bet?Zacks Investment Research • 08/27/25
Billionaire Stanley Druckenmiller Just Bought the Dip on This Beaten-Down GLP-1 Stock (Hint: It's Not Eli Lilly or Novo Nordisk)The Motley Fool • 08/27/25
2 Biotech Stocks That Could Soar 21% and 245% According to Wall Street's Top AnalystsThe Motley Fool • 08/24/25
Viking Therapeutics' Stock Tanks on Mixed Data From Obesity Pill StudyZacks Investment Research • 08/20/25
Viking Obesity Pill Faces Steep Climb Against Lilly's Tirzepatide, Analyst Calls Downtrend Reaction 'Extreme'Benzinga • 08/19/25
Viking Therapeutics shares plunge on weight loss trial tolerability concernsProactive Investors • 08/19/25
Viking Therapeutics: Wall Street Mistaken To Dump After Obesity Pill Study SuccessSeeking Alpha • 08/19/25
Viking Therapeutics shares fall more than 30% on disappointing obesity pill trial dataCNBC • 08/19/25
Like Eli Lilly, Viking Therapeutics' Oral Weight Loss Drug Disappoints, Stock TanksBenzinga • 08/19/25